Tag: Pancreatic Cancer

Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA

Presented By
Dr Serena Stigliano, University of Rome, Italy
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:21

Neoadjuvant chemoradiation does not improve surgical outcomes or survival in pancreatic cancer

Presented By
Dr Aurélien Lambert, Lorraine Cancer Institute, France
Trial
Phase 2, PANDAS/PRODIGE 44
Conference
ESMO 2024
Type
Peer-reviewed article

4 November 2024 13:18

No advantage of neoadjuvant radiochemotherapy over neoadjuvant chemotherapy in borderline resectable pancreatic cancer

Presented By
Dr Masafumi Ikeda, National Cancer Center Hospital East, Japan
Trial
Phase 3, GABARNANCE
Conference
ASCO 2024
Type
Peer-reviewed article

18 July 2024 15:06

Encouraging preliminary data for glecirasib in pancreatic ductal adenocarcinoma

Presented By
Dr Jian Li, Peking University Cancer Hospital and Institute, China
Trial
Phase 1/2, JAB-21822-1001, JAB-21822-1002
Conference
ASCO GI 2024
Type
News article

13 February 2024 12:51

ALPACA: Promising results for dose de-escalated regimen of gemcitabine/nab-paclitaxel in metastatic PDAC

Presented By
Prof. Frank Kullmann, Hospital Weiden, Germany
Trial
Phase 2, ALPACA (AIO-PAK-0114)
Conference
ASCO GI 2024
Type
News article

13 February 2024 12:48

Championing the cause against pancreatic cancer – Interview with Ali Stunt

Expert
Ms Ali Stunt, Pancreatic Cancer Action, Bordon, UK

13 November 2023 12:02

No improved OS in pancreatic cancer after neoadjuvant mFOLFIRINOX

Presented By
Prof. Knut Labori, Oslo University Hospital, Norway
Trial
Phase 2, NorPACT-1
Conference
ASCO 2023
Type
Peer-reviewed article

2 August 2023 09:35

First-line NALIRIFOX superior to standard treatment in mPDAC

Presented By
Prof. Zev Wainberg, University of California Los Angeles, CA, USA
Trial
Phase 3, NAPOLI-3
Conference
ASCO GI 2023
Type
Peer-reviewed article

17 March 2023 09:37

Novel approach delivers quality-of-life benefits for patients with pancreatic cancer

Presented By
Dr Yaacov Lawrence, Sheba Medical Center, Israel
Conference
ASCO GI 2023
Type
Peer-reviewed article

17 March 2023 09:34

Detection of Europe´s deadliest cancer: much room for improvement

Presented By
Dr Nosheen Umar, University of Birmingham, UK
Conference
UEGW 2022
Type
Peer-reviewed article

2 December 2022 09:21

UEGW 2022 Highlights Podcast

Presented By
Robert van den Heuvel, Medicom
Conference
UEGW 2022

13 October 2022 22:43

Novel treatment option for KRAS wildtype pancreatic cancer 

Presented By
Prof. Shukui Qin, Cancer Center of Jinling Hospital, China
Trial
Phase 3, NOTABLE
Conference
ASCO 2022
Type
Peer-reviewed article

5 August 2022 15:03

Sintilimab plus FOLFIRINOX may provide benefits in metastatic pancreatic cancer

Presented By
Dr Qihan Fu, Zhejiang University School of Medicine, China
Trial
Phase 3, CISPD3
Conference
ASCO GI 2022
Type
Peer-reviewed article

21 March 2022 12:43

TRYbeCA-1: Eryaspase + chemotherapy does not meet primary endpoint in pancreatic cancer

Presented By
Prof. Pascal Hammel, Université Paris VII, France
Trial
Phase 3, TRYbeCA-1
Conference
ASCO GI 2022
Type
Peer-reviewed article

21 March 2022 12:40

Persisting disparities in pancreatic cancer care

Presented By
Prof. Susan Tsai, Medical College of Wisconsin, WI, USA
Conference
ASCO GI 2022
Type
Peer-reviewed article

21 March 2022 12:38

ctDNA promising biomarker for recurrence of pancreatic cancer

Presented By
Dr Gregory Botta, UCSD Moores Cancer Center, CA, USA
Conference
ASCO GI 2022
Type
Peer-reviewed article

21 March 2022 12:32

Duloxetine ameliorates oxaliplatin-induced peripheral neuropathy

Presented By
Dr Jeffrey Chi, Northwell Health Cancer Institute, NY, USA
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 11:31

Borderline resectable pancreatic cancer: phase 2 results

Presented By
Prof. Matthew H. Katz, University of Texas MD Anderson Cancer Center, USA
Trial
Phase 2, Alliance A021501
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 11:12

No survival benefit for olaparib in BRCA-mutated metastatic pancreatic cancer

Presented By
Prof. Talia Golan, Sheba Medical Center, Israel
Trial
Phase 3, POLO
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 11:02

Metastatic pancreatic adenocarcinoma: second-line naI-IRI plus 5-FU/LV

Presented By
Prof. Kyunghye Bang, Asan Medical Center, Korea
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 10:59

Metal stents are better than plastic for endoscopic biliary drainage

Presented By
Dr Anouk Latenstein, Amsterdam University Medical Center, the Netherlands
Trial
DROP
Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 20:12

Global burden of digestive diseases reveals alarming trends

Trial
The Global Burden of Disease
Conference
UEGW 2019
Type
Peer-reviewed article

23 October 2019 17:46

Maintenance olaparib improved PFS in patients with BRCA+ pancreatic cancer

Presented By
Dr Hedy L. Kindler, The University of Chicago, USA
Trial
Phase 3, POLO
Conference
ASCO 2019
Type
Peer-reviewed article

15 July 2019 14:07

First-in-human study shows IL1RAP-targeting drug safe in solid tumours

Presented By
Dr Ahmad Awada, Institut Jules Bordet, Belgium
Conference
ASCO 2019
Type
Peer-reviewed article

15 July 2019 13:58
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com